Darbepoetin alfa
- Generic Name
- Darbepoetin alfa
- Brand Names
- Aranesp
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 209810-58-2
- Unique Ingredient Identifier
- 15UQ94PT4P
- Background
Human erythropoietin with 2 aa substitutions to enhance glycosylation (5 N-linked chains), 165 residues (MW=37 kD). Produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology.
- Indication
For the treatment of anemia (from renal transplants or certain HIV treatment)
- Associated Conditions
- Anemia
- Associated Therapies
- -
Big Pharma Doubles Down on China
Eli Lilly invests $212 million to expand its Suzhou plant, following China's approval of its weight loss drug Zepbound. Other pharmaceutical giants like Bayer and Roche also expand in China, highlighting the sector's resilience amid economic challenges. China's healthcare sector reforms and large market attract foreign investment, despite pricing pressures and competition from local firms. Multinationals increasingly partner with Chinese biotech companies for innovation and market access.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath